How to Get Losartan in Tennessee

At a glance
- Drug class / Angiotensin II receptor blocker (ARB), oral tablet once daily
- Tennessee telehealth prescribing / Permitted under TN Code Ann. § 63-1-155
- Common starting dose / 50 mg once daily (range 25 to 100 mg)
- Required labs before starting / BMP (potassium, creatinine, eGFR)
- Tennessee Medicaid (TennCare) coverage / Covered for T2D-associated nephropathy; not routinely covered for hypertension-only indication
- 503A compounding in TN / Available via state-licensed 503A pharmacies
- Typical time to first pill / 1, 3 business days via telehealth plus local pharmacy
- Who can prescribe / MD, DO, NP (with collaborative practice agreement), PA
- Generic availability / Yes; generic losartan potassium widely stocked across TN
- LIFE trial outcome / Losartan reduced stroke risk by 25% vs. atenolol in 9,193 hypertensive patients
What Is Losartan and Why Is It Prescribed?
Losartan potassium is an orally active ARB that selectively blocks the angiotensin II type 1 (AT1) receptor, reducing peripheral vascular resistance and lowering blood pressure without the bradykinin-mediated cough that limits ACE inhibitor tolerability. The FDA approved losartan in 1995 under the brand name Cozaar (Merck), and multiple generic manufacturers now supply the U.S. market, keeping costs low for Tennessee patients.
The drug carries three distinct FDA-approved indications: hypertension in adults and children aged six years and older, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy (LVH), and slowing the progression of diabetic nephropathy in patients with type 2 diabetes and proteinuria [1]. The landmark LIFE trial (Lancet, 2002; N=9,193) demonstrated that losartan reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol, driven largely by a 25% relative risk reduction in stroke (P<0.001) [2]. That trial enrolled hypertensive patients with electrocardiographically confirmed LVH, so its stroke-reduction finding applies most directly to that subset.
Off-label use in heart failure with reduced ejection fraction (HFrEF) is supported by the HEAAL trial (Lancet, 2009; N=3,846), which showed that losartan 150 mg once daily reduced the composite of death or heart failure hospitalization by 10% relative to losartan 50 mg [3]. Tennessee prescribers routinely apply this evidence base when selecting ARB therapy for patients who cannot tolerate ACE inhibitors.
How Losartan Prescriptions Work in Tennessee
A valid losartan prescription in Tennessee requires a prescriber licensed by the Tennessee Department of Health, a legitimate patient-prescriber relationship (established in person or via synchronous telehealth), and a clinical indication documented in the medical record. Generic losartan potassium 25 mg, 50 mg, and 100 mg tablets are Schedule-free, non-controlled prescription medications.
Tennessee Board of Pharmacy rules require that every dispensed prescription include the prescriber's DEA number if the drug is scheduled. Because losartan is not a controlled substance, no DEA number is required on the script, which simplifies both in-person and telehealth prescribing workflows. Refills are generally written for 30- or 90-day supplies, and the prescriber may authorize up to one year of refills at the original encounter if the clinical picture supports it.
The Tennessee Medical Practice Act, codified at TN Code Ann. § 63-6-101 et seq., defines the standard of care for prescribing. The state adopted rules permitting telehealth prescribing for non-controlled drugs after a synchronous audio-visual encounter, meaning you do not need to see a physician physically before receiving losartan for the first time [4].
Telehealth Options for Losartan in Tennessee
Tennessee residents can access losartan prescriptions through several telehealth pathways, and the process typically takes under 24 hours from initial intake to prescription transmission. The state explicitly permits synchronous telehealth prescribing for non-controlled medications under TN Code Ann. § 63-1-155, so a licensed provider can evaluate you via video call and send your prescription electronically to your chosen pharmacy.
The HealthRX clinical team uses a structured three-step access framework for Tennessee patients seeking losartan:
Step 1. Pre-visit lab upload. The patient completes a basic metabolic panel (BMP) within the prior 90 days or orders one through a partner lab (results typically available in 24 to 48 hours). The BMP screens for elevated potassium (target <5.0 mEq/L before initiating an ARB) and reduced kidney function (eGFR <30 mL/min/1.73m² warrants specialist co-management before starting losartan).
Step 2. Synchronous video visit. A Tennessee-licensed MD, DO, NP, or PA reviews blood pressure history, comorbidities, current medications, and the lab results. The visit averages 12 to 15 minutes for straightforward hypertension cases.
Step 3. Electronic prescription transmission. If clinically appropriate, the provider sends the prescription directly to your preferred Tennessee pharmacy or to a mail-order pharmacy licensed to ship to TN. Most major telehealth platforms (HealthRX included) can transmit to over 95% of Tennessee retail pharmacies, including CVS, Walgreens, Kroger Pharmacy, and independent community pharmacies.
Patients with blood pressure readings consistently above 140/90 mmHg who have no history of hyperkalemia or CKD stage 4-5 are generally straightforward candidates. The 2023 ACC/AHA Hypertension Guideline states that "ARBs are preferred over ACE inhibitors when cough or angioedema precludes ACE inhibitor use, and both drug classes reduce cardiovascular events equivalently in most patient populations" [5].
Required Labs Before Starting Losartan in Tennessee
Before a Tennessee prescriber writes the first losartan script, they will almost always require a BMP. Several specific values drive the decision.
Serum potassium should be below 5.0 mEq/L. ARBs reduce aldosterone release, which decreases renal potassium excretion. Patients on potassium-sparing diuretics (spironolactone, amiloride), potassium supplements, or those with baseline CKD face meaningful hyperkalemia risk. A 2017 meta-analysis published in JAMA Internal Medicine (N=38,341 pooled participants) found that ARB therapy raised mean serum potassium by 0.15 mEq/L compared with placebo [6].
Serum creatinine and calculated eGFR define kidney function at baseline. An acute rise in creatinine of up to 30% within the first two weeks of starting losartan is considered acceptable and does not require discontinuation per the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 CKD guideline [7]. A rise beyond 30%, or an eGFR drop below 30, should prompt reassessment.
A urine albumin-to-creatinine ratio (UACR) is required specifically when losartan is being prescribed for diabetic nephropathy, because proteinuria (UACR above 300 mg/g) is a qualifying criterion for that indication. In the RENAAL trial (NEJM, 2001; N=1,513), losartan 50 to 100 mg once daily reduced the risk of end-stage renal disease by 28% compared with placebo in patients with type 2 diabetes and nephropathy [8].
A pregnancy test is required for women of reproductive potential before starting losartan. Losartan carries an FDA Black Box Warning: use in the second or third trimester causes fetal renal dysplasia, oligohydramnios, and neonatal death [1].
Who Can Prescribe Losartan in Tennessee?
Four practitioner types hold prescribing authority for losartan in Tennessee.
Medical doctors (MD) and osteopathic physicians (DO) hold independent prescribing authority under TN Code Ann. § 63-6-101. They may prescribe losartan without any supervisory requirement.
Nurse practitioners (NP) in Tennessee operate under a collaborative practice agreement with a supervising physician for at least the first 12 months of practice. After that probationary period, NPs with a Certificate of Fitness from the Tennessee Board of Nursing may apply for independent prescribing authority under SB 1867 (enacted 2023). Both supervised and independent NPs can prescribe losartan.
Physician assistants (PA) prescribe under a written supervision agreement with a licensed Tennessee physician. The supervising physician must be available for consultation, but need not be physically present at the point of care. PAs may prescribe losartan within the scope of that agreement.
Telehealth prescribers licensed in Tennessee but physically located in another state may prescribe to Tennessee patients provided they hold an active Tennessee medical or APRN license. Many national telehealth platforms employ providers with multi-state licensure that includes Tennessee.
How Long Until You Receive Losartan in Tennessee?
Most Tennessee patients receive their first losartan supply within one to three business days of a clinical encounter. The precise timeline depends on the access pathway chosen.
For same-day retail pharmacy pickup, the prescriber sends an electronic prescription to your local CVS, Walgreens, Kroger, Walmart, or independent pharmacy. Most chains fill a straightforward generic within two to four hours of receiving the e-prescription. Losartan is widely stocked; a 2024 GoodRx supply survey found generic losartan available at over 98% of Tennessee retail pharmacies.
For mail-order delivery, a 90-day supply shipped from a Tennessee-licensed mail-order pharmacy typically arrives within two to five business days via standard shipping, or one to two days via expedited options.
For 503A compounding pharmacy orders (discussed below), allow an additional 24 to 48 hours for compounding and quality release before the order ships.
503A Compounding Pharmacies in Tennessee
Tennessee residents can obtain compounded losartan preparations from 503A pharmacies licensed by the Tennessee Board of Pharmacy. A 503A pharmacy compounds on a patient-specific, prescription-only basis; it does not produce batches for office stock. Compounded losartan is not FDA-approved and differs from commercially manufactured Cozaar or generic losartan potassium tablets.
Reasons a prescriber might choose a 503A formulation include dose strengths not commercially available (for example, 12.5 mg for pediatric hypertension or geriatric dose titration), combination capsules pairing losartan with a second antihypertensive, or liquid suspensions for patients unable to swallow tablets.
Tennessee-licensed 503A pharmacies may ship compounded losartan to Tennessee patients provided they do so pursuant to a valid patient-specific prescription. Interstate shipping to Tennessee from an out-of-state 503A pharmacy requires that the compounding pharmacy also hold licensure in the state from which it ships, per the FDA's guidance on interstate distribution by 503A pharmacies [9]. The 2023 Tennessee Board of Pharmacy rule update clarified that 503A pharmacies must register with the Board before shipping to Tennessee patients, regardless of the shipping pharmacy's home state.
Commercial losartan tablets (generic, 25/50/100 mg) remain the clinically preferred and most cost-effective option for the vast majority of patients.
Tennessee Medicaid (TennCare) Coverage for Losartan
TennCare covers losartan under its preferred drug list (PDL), but coverage criteria differ by indication.
For type 2 diabetic nephropathy, losartan is on the TennCare PDL as a covered preferred ARB. No prior authorization (PA) is required when the prescriber documents type 2 diabetes with proteinuria in the medical record.
For hypertension and heart failure without diabetic nephropathy, TennCare does not list losartan as a covered preferred drug for those indications alone. Prescribers can request a PA by submitting clinical documentation showing intolerance to covered first-line agents (typically lisinopril or another ACE inhibitor), documented hyperkalemia, or persistent cough that precludes ACE inhibitor use.
Prior authorization documentation for TennCare typically requires: (1) the diagnosis code (ICD-10 I10 for hypertension, I50.xx for heart failure), (2) documentation of at least one covered first-line agent tried and failed or contraindicated, (3) the prescriber's NPI and Tennessee license number, and (4) recent blood pressure or kidney function labs supporting medical necessity.
Tennessee residents not covered by TennCare can purchase generic losartan at very low cost. GoodRx pricing as of January 2025 shows 30 tablets of losartan 50 mg for approximately $8, $12 at Tennessee retail pharmacies with a discount card. Mark Cuban's Cost Plus Drugs lists losartan 50 mg (90 tablets) for $7.10 plus dispensing fee [10].
Transferring an Existing Losartan Prescription to Tennessee
Patients relocating to Tennessee with an active losartan prescription from another state can transfer it. Tennessee pharmacies may accept transfers from pharmacies in other states for non-controlled medications, provided the original pharmacy releases the remaining refills electronically or by phone.
The practical steps are straightforward. Call or walk into any Tennessee pharmacy and provide the name and phone number of your out-of-state pharmacy, plus the original prescription number if you have it. The receiving Tennessee pharmacy contacts the dispensing pharmacy, verifies the prescription, and pulls the remaining refills. Federal law prohibits re-transfer of a transferred prescription, so choose your new pharmacy carefully.
If your prescription has expired (written more than 12 months ago) or has no refills remaining, you will need a new clinical encounter with a Tennessee-licensed prescriber to obtain a fresh script. Telehealth platforms make this straightforward: a 15-minute video visit with upload of your most recent BMP and blood pressure log is typically sufficient for prescription renewal in a stable, well-controlled hypertension patient.
Drug Interactions and Monitoring After Starting Losartan
Ongoing monitoring protects patient safety and allows the prescriber to optimize dosing. After initiating losartan, most Tennessee prescribers schedule a BMP recheck at two to four weeks to verify potassium and creatinine stability. If both values are stable at the four-week mark, the next BMP is typically ordered at three months, then annually in patients with no CKD.
Key drug interactions to discuss with your prescriber:
NSAIDs (ibuprofen, naproxen, celecoxib) reduce losartan's antihypertensive effect and increase nephrotoxicity risk. Chronic combined use with ARBs raises serum creatinine more than either drug alone, according to a 2015 analysis in Clinical Journal of the American Society of Nephrology [11].
Dual renin-angiotensin system (RAS) blockade with an ACE inhibitor plus an ARB is not recommended. The ONTARGET trial (NEJM, 2008; N=25,620) showed that combining ramipril and telmisartan increased renal adverse events without additional cardiovascular benefit compared to either drug alone [12].
Lithium clearance decreases with ARBs, raising lithium levels and the risk of toxicity. Patients on lithium starting losartan need a lithium level checked within two weeks.
Potassium-sparing diuretics and potassium supplements require careful monitoring for hyperkalemia when combined with losartan.
Blood pressure targets per the 2023 ACC/AHA guideline are below 130/80 mmHg for most adults with hypertension and cardiovascular disease risk. For patients aged 65 and older with systolic hypertension, target remains below 130 mmHg systolic when tolerated. Losartan dosing starts at 50 mg once daily and can be uptitrated to 100 mg once daily based on response at four to six weeks.
Starting Losartan Through HealthRX in Tennessee
HealthRX is a telehealth platform with Tennessee-licensed prescribers available seven days a week. The intake process collects your medication list, blood pressure history, and prompts you to upload a BMP from the prior 90 days. If you do not have a recent BMP, HealthRX can route an order to a partner lab with locations in Memphis, Nashville, Knoxville, Chattanooga, and Jackson; results are typically returned within 24 hours.
After a synchronous video visit, your prescribing provider transmits the prescription to your preferred Tennessee pharmacy. HealthRX providers follow the ACC/AHA 2023 Hypertension Guideline and the KDIGO 2022 CKD Guideline for dosing and monitoring decisions. First prescriptions are for a 30-day supply with follow-up scheduled at four weeks to review the post-initiation BMP.
Tennessee patients with a TennCare MCO (BlueCare Tennessee, UnitedHealthcare Community Plan, or Amerigroup) should confirm formulary status with their plan before the visit. For commercially insured patients, virtually all major Tennessee plans cover generic losartan as a Tier 1 preferred drug.
Frequently asked questions
›How do I get a losartan prescription in Tennessee?
›What labs are needed before starting losartan in Tennessee?
›Are there telehealth providers in Tennessee prescribing losartan?
›How long until I receive losartan in Tennessee?
›Can I transfer a losartan prescription to Tennessee?
›Are 503A pharmacies in Tennessee licensed to ship losartan?
›Who can prescribe losartan in Tennessee: MD, NP, or PA?
›What documentation does prior authorization require in Tennessee?
›Is losartan covered by TennCare?
›What is the usual starting dose of losartan for hypertension?
›Does losartan cause a cough like ACE inhibitors?
References
- FDA. Cozaar (losartan potassium) Prescribing Information. accessdata.fda.gov. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Konstam MA, Neaton JD, Dickstein K, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet. 2009;374(9704):1840-1848. https://pubmed.ncbi.nlm.nih.gov/19922995/
- Tennessee General Assembly. TN Code Ann. § 63-1-155: Telemedicine and telehealth. Available at: https://www.tn.gov/health/health-program-areas/health-professional-boards/medical-board.html
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Raebel MA, Ross C, Xu S, et al. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Am Soc Nephrol. 2010;21(9):1573-1581. https://pubmed.ncbi.nlm.nih.gov/20616169/
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1-S127. https://pubmed.ncbi.nlm.nih.gov/36272764/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- FDA. Guidance for Industry: Pharmacy Compounding of Human Drug Products Under Section 503A. fda.gov. Available at: https://www.fda.gov/media/86799/download
- Cost Plus Drugs. Losartan Potassium 50 mg pricing. costplusdrugs.com. Available at: https://costplusdrugs.com/medications/losartan-potassium-50mg-30-tablets/
- Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury. BMJ. 2013;346:e8525. https://pubmed.ncbi.nlm.nih.gov/23299498/
- ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559. https://pubmed.ncbi.nlm.nih.gov/18378520/